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The diagnosis of metabolic diseases is challenging. Most of them have 
poor prognosis, leading to early death, whereas milder forms, juvenile and 
adult live longer. MRI can be of help in some conditions, but in most cases 
extensive investigations, including genetic tests are needed to reach diagnosis. 
Several classifications have been proposed for these disorders. They can be 
classified according to the cell organelle involved, whether it is the lysosome, 
peroxisome, or mitochondrion, or the underlying biochemical defect. These 
classifications are, however less helpful because there are no characteristic 
imaging findings shared by all diseases. The classification to gray and white 
matter diseases is, although simple and practical and therefore widely used. 
In some conditions, the involvement of specific white matter tracts can be a 
diagnostic clue. The deep gray nuclei are affected in many metabolic diseases, 
also in those with primarily white matter imaging findings, but the results have 
so far been discouraging because of the large variability of presentations of 
these disorders. To achieve images of any diagnostic value the patient must be 
imaged early in the course of the disease.
Niemann-Pick type C disease (NPC) is a rare autosomal recessive lipid storage 
disorder caused by impaired cellular functions in processing and transport of 
LDL-cholesterol. The symptoms are usually clumsiness and gait disturbance 
at the beginning, and include ataxia, mental disturbance, dystonia, dysarthria, 
dysphagia, seizures and vertical supranuclear gaze palsy during the disease 
course. Mutations of the NPC1 gene, located on chromosome 18q11-12, are 
observed in 95% of NPC patients, whereas mutations of the NPC2 gene are 
noted in 5%. It has been proposed that the mutations in the NPC genes cause 
blockage of cholesterol transport between lysosomes and the sterol regulator 
machinery, so that excessive cholesterol is accumulated and apoptosis of 
neurons occurs. The intracellular accumulation of unesterified cholesterol in 
the lysosomal system can be detected from the fluorescence level around the 
nucleus, via filipin staining. To reach a conclusive diagnosis of NPC, both 
the abnormal accumulation of cholesterol and LDL-cholesterol esterification 
in fibroblast cell culture should be observed. For NPC, brain MRI usually 
is not capable of detecting abnormality except in the late stages. MRS the 
neuroimaging technique for obtaining information about brain metabolism 
shows decreased N-acetyl aspartate indicates neuronal and axonal loss, whereas 
increased choline reflects demyelination or gliosis. In addition, 18-fluoro-2- 
deoxyglucose (F-18 FDG) positron emission tomography (PET), based on 
glucose utilization in the brain, is known to be sensitive for the detection of 
metabolic derangements in patients with neurodegenerative disorders.
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